---
title: Cell Therapies vs eXmoor Pharma
slug_a: celltherapies
slug_b: exmoorpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/celltherapies/exmoorpharma
---

# Cell Therapies vs eXmoor Pharma

Side-by-side profile data from each company listing on this directory.

## Cell Therapies

- Profile: [/companies/celltherapies](/companies/celltherapies)

Cell Therapies — GMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.

Services: 9. Modalities: 2. Indications: 1. Locations: 1. Certifications: 4. The strongest documented coverage currently appears in services (9).

### Services

- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## eXmoor Pharma

- Profile: [/companies/exmoorpharma](/companies/exmoorpharma)

eXmoor Pharma — Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Single-Use / Disposable